Redeye retains its positive view of Transtema despite a softer-than-expected Q1. While H1 2026 will be a lost half-year for profits, the important thing is that Transtema continues to progress well with its long-term initiatives to strengthen margins, set to improve profitability from H2 2026.
LÄS MER
